Clinical evidence remains limited and outcomes vary by patient
The TNSS is a four-symptom scale (nasal obstruction, rhinorrhea, sneezing, and itching), with each symptom scored from 0 (no symptoms) to 3 (severe), resulting in a total score ranging from 0 to 12
Trends in Endocrinology & Metabolism , 29(6), 423-435
Recovery camp: BPC-157 and TB-500 (the Wolverine blend) are used for repair and post-training recovery, with evidence that is promising but still largely preclinical
The pattern in patient reviews: those reporting substantial weight loss (10+ pounds in 4 weeks) invariably mention concurrent dietary changes, increased exercise, or use of other medications (metformin, GLP-1 agonists)